Cordasco Financial Network’s Regeneron Pharmaceuticals REGN Stock Holding History

Cordasco Financial Network’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$12K	Buy	+20	New	+$13K	0.01%	346

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Cordasco Financial Network's REGN Position: Q2 2022 in Review

Cordasco Financial Network opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2022: 20 shares worth $12K. The stake represents 0.01% of the portfolio and ranks #346 among its holdings.

1,063 funds tracked by Wall St. Rank hold REGN as of Q2 2022.

Cordasco Financial Network held 20 shares of Regeneron Pharmaceuticals worth $12K as of Q2 2022.
Regeneron Pharmaceuticals was a new Cordasco Financial Network position in Q2 2022.
Regeneron Pharmaceuticals made up 0.01% of Cordasco Financial Network's portfolio in Q2 2022, its #346 holding.
1,063 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2022.

Based on Cordasco Financial Network's 13F filing for Q2 2022, filed 15 Jul 2022.